扶桑薬品工業株式会社
Ranked #1,257 among listed Japanese companies by corporate taxes paid · effective tax rate 17.5%.
Share price at fiscal year-end: ¥2,356 · market capitalization ¥22.3B · P/E 10.0 · P/B 0.64
US dollar amounts use ¥157.8 per dollar.
| Fiscal year | Revenue | Net income | Tax expense | Taxes paid | Total assets | Net assets | Equity ratio | Source |
|---|---|---|---|---|---|---|---|---|
| Mar 2026 | ¥62.3B | ¥2.0B | ¥426M | ¥1.3B | ¥90.3B | ¥35.1B | 38.8% | EDINET |
| Mar 2025 | ¥60.6B | −¥3.3B | −¥1.7B | ¥374M | ¥81.7B | ¥33.0B | 40.4% | EDINET |
| Mar 2024 | ¥55.4B | ¥1.4B | — | — | ¥75.8B | ¥36.7B | 48.4% | EDINET |
| Mar 2023 | ¥51.0B | ¥1.6B | — | — | ¥72.5B | ¥35.6B | 49.2% | EDINET |
| Mar 2022 | ¥49.6B | ¥1.5B | — | — | ¥69.3B | ¥34.5B | 49.8% | EDINET |
From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）
See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.